SMN1 and proximal spinal muscular atrophy: Based on these encouraging results, Torres-Benito et al. [89] developed an ASO-based therapy to target Ncald in mouse spinal cord and used it in combination with low-dose SMN splice switching ASOs to design an efficient combinatorial therapy in SMA mice [89].